Inventor · disambiguated record
Yam B. Poudel
Also filed as: POUDEL YAM · POUDEL YAM B · POUDEL YAM BAHADUR
25 granted patents·12 pending applications·97 citations·filing 2010–2025
94Inventor score
Top patents by PatentIndex Score
37 records- 0196US10457681B2Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 29, 2019·15 cites·9 claims
- 0295US10487084B2Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 26, 2019·16 cites·15 claims
- 0395US10472361B2Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 12, 2019·16 cites·6 claims
- 0494US10508115B2Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 17, 2019·13 cites·19 claims
- 0594US10494370B2Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 3, 2019·15 cites·6 claims
- 0693US10898578B2Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and makingBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jan 26, 2021·4 cites·21 claims
- 0792US11400094B22H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 2, 2022·4 cites·18 claims
- 0886US11554120B21H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jan 17, 2023·4 cites·13 claims
- 0981US9777013B2Derivatives of uncialamycin, methods of synthesis and their use as antitumor agentsUNIV RICE WILLIAM M·Filed 2014·Granted Oct 3, 2017·4 cites·21 claims
- 1080US2024165249A1Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and makingBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1177US10723736B2Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 28, 2020·0 cites·1 claims
- 1277US10711003B2Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 14, 2020·0 cites·1 claims
- 1375US2023140047A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS AND METHODS AND USES THEREFORBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1474US10913741B2Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 9, 2021·0 cites·1 claims
- 1574US10689382B2Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 23, 2020·0 cites·1 claims
- 1673US10793569B2Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Oct 6, 2020·0 cites·1 claims
- 1772US10941145B2Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Mar 9, 2021·0 cites·1 claims
- 1872US10927114B2Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 23, 2021·0 cites·1 claims
- 1972US10919895B2Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 16, 2021·0 cites·1 claims
- 2072US10696676B2Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 30, 2020·0 cites·1 claims
- 2172US9096550B2Bryostatin analogues and methods of making and using thereofKECK GARY E·Filed 2010·Granted Aug 4, 2015·6 cites·35 claims
- 2271US11911483B2Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and makingBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 27, 2024·0 cites·6 claims
- 2371US10889590B2Derivatives of uncialamycin, methods of synthesis and their use as antitumor agentsUNIV RICE WILLIAM M·Filed 2019·Granted Jan 12, 2021·0 cites·20 claims
- 2465US10981914B2Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 20, 2021·0 cites·2 claims
- 2555US12485123B21H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonistsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Dec 2, 2025·0 cites·10 claims
- 2654US10233192B2Derivatives of uncialamycin, methods of synthesis and their use as antitumor agentsUNIV RICE WILLIAM M·Filed 2017·Granted Mar 19, 2019·0 cites·21 claims
- 2753US2023041738A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2853US2023122249A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2953US2023140430A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 3053US2023348468A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 3152US2025282786A1Tricyclic TLR7 Agonists and Uses ThereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 3252US2023127326A1C3-SUBSTITUTED 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 3352US2023144824A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 3452US2023118688A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 3549US11485741B2Macrocyclic toll-like receptor 7 (TLR7) agonistsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 1, 2022·0 cites·18 claims
- 3645US2025282776A1Bicyclic TLR7 Agonists and Uses ThereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 3735US2017239212A1Bryostatin analogs and use thereof as antiviral agentsUNIV UTAH RES FOUND·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →